TipRanks
BioMark Diagnostics (DE:20B)
FRANKFURT:20B
Germany Market
20B
BioMark Diagnostics
RESEARCH TOOLSreports

BioMark Diagnostics (20B) Balance Sheet

5 Followers

BioMark Diagnostics Balance Sheet

BioMark Diagnostics's total assets for Q4 2026 were C$1.86M, a decrease of -14.13% from the previous quarter. DE:20B total liabilities were C$1.53M for the fiscal quarter, a -4.14% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Jun 26Jun 25Jun 24Jun 22Jun 21
Total Assets
C$ 1.86MC$ 3.13MC$ 1.09MC$ 732.29KC$ 952.94K
Total Liabilities
C$ 1.53MC$ 1.39MC$ 1.70MC$ 1.88MC$ 1.03M
Total Equity Gross Minority
C$ 331.06KC$ 1.74MC$ -609.61KC$ -1.15MC$ -79.09K
Other Metrics
Currency in CAD

BioMark Diagnostics Debt to Assets